Task: Answer the MCQ question.
Question: Which drug exhibits a 7.376% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) Cc1sc(NC(=O)CSc2nnnn2C(C)C)c(C#N)c1C
b) O=c1c2cc3c(=O)n(-c4ccccc4O)c(=O)c3cc2c(=O)n1-c1ccccc1O
c) O=C(NCCCn1ccnc1)/C(=C\c1ccccc1F)NC(=O)c1ccccc1
Answer: a. Cc1sc(NC(=O)CSc2nnnn2C(C)C)c(C#N)c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1sc(NC(=O)CSc2nnnn2C(C)C)c(C#N)c1C
Cc1sc(NC(=O)CSc2nnnn2C(C)C)c(C#N)c1C
N-(3-cyano-4,5-dimethylthiophen-2-yl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide